MyHealthChecked PLC Confirmation of Capital Reduction (0373N)
18 Janvier 2023 - 8:01AM
UK Regulatory
TIDMMHC
RNS Number : 0373N
MyHealthChecked PLC
18 January 2023
MyHealthChecked PLC
( " MyHealthChecked " or the "Company " )
Confirmation of Capital Reduction
Further to the announcement made by the Company on 6 December
2022, MyHealthChecked PLC (AIM: MHC), announces today that the
reduction of capital (the "Capital Reduction"), involving the
cancellation of the Deferred Shares, the Share Premium Account and
the Capital Redemption Reserve of the Company, has been confirmed
by the High Court of Justice of England and Wales (the
"Court").
The Court order confirming the Capital Reduction, and a
statement of capital approved by the Court, is expected to be
registered with the Registrar of Companies no later than 31 January
2023.
Full details of the Capital Reduction are set out in the notice
of general meeting which was sent to shareholders of the Company on
18 November 2022 (the "Notice"). The Notice is also available for
inspection on the Company's website.
For further information contact:
MyHealthChecked PLC www.myhealthchecked.com
Penny McCormick, Chief Executive via Walbrook PR
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin
Dowgate Capital Limited (Broker Tel: +44 (0)20 3903 7715
)
David Poutney / Nicholas Chambers
Walbrook PR Ltd (Media Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
& IR)
Paul McManus Mob: +44 (0)7980 541 893
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company focused on a range of at-home
healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA
and RNA tests that have been developed following the acquisition of
The Genome Store in November 2020. The tests are available online,
and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
FURNKOBBOBKDFDD
(END) Dow Jones Newswires
January 18, 2023 02:01 ET (07:01 GMT)
Concepta (LSE:CPT)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Concepta (LSE:CPT)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024